Subscribe: Prostate / Prostate Cancer News From Medical News Today
Added By: Feedage Forager Feedage Grade A rated
Language: English
aggressive prostate  cancer patients  cancer  new  patients  prostate cancer  prostate  risk  study finds  study  therapy  treatment 
Rate this Feed
Rating: 1.7 starRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Prostate / Prostate Cancer News From Medical News Today

Prostate / Prostate Cancer News From Medical News Today

Prostate cancer is the most common cancer in men. Prostate cancer develops slowly, and there may be no signs that you have it for many years. Symptoms often only become apparent when your prostate is large enough to affect the urethra. Treatment options i

Copyright: Copyright 2016 Medical News Today

Smokeless tobacco product snus may increase risk of death among prostate cancer patients

Fri, 14 Oct 2016 00:00:00 PDT

The smokeless tobacco product snus, which is used mainly in Sweden but also is sold in the U.S.

Hormone therapy for prostate cancer may raise dementia risk

Thu, 13 Oct 2016 08:00:00 PDT

Men treated with androgen deprivation therapy - a hormone therapy - for prostate cancer may be more than twice as likely to develop dementia, study finds.

Born rich or poor? Where you begin life affects cancer risk later

Wed, 12 Oct 2016 09:00:00 PDT

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah has announced the results of a study that found that circumstances in childhood, such as parental occupation at birth and...

Custirsen shows no survival benefits in metastatic prostate cancer

Wed, 12 Oct 2016 00:00:00 PDT

A phase III randomized controlled trial of custirsen in combination with cabazitaxel/prednisone in patients with previously-treated metastatic, castration-resistant prostate cancer has shown no...

Prospective, multi-institutional study shows five treatments with the CyberKnife system provide excellent disease control for prostate cancer patients

Mon, 03 Oct 2016 05:00:00 PDT

Accuray Incorporated has announced that data from a prospective, 21 center study showed 97 percent of low- and intermediate-risk prostate cancer patients had excellent cancer control five years...

How Does Prostate Cancer Affect Sex?

Fri, 30 Sep 2016 07:00:00 PDT

Men having treatment for prostate cancer can have problems with sex. Learn about what causes these problems and what treatments are available.

Enlarged prostate: Molecular mechanism clue may explain link to inflammation

Tue, 06 Sep 2016 07:00:00 PDT

Discovery of molecular mechanism may explain how inflammation leads to benign prostatic hyperplasia and improve response to androgen-targeted therapies.

A gene defect as a potential gateway for targeted prostate cancer therapy

Tue, 06 Sep 2016 07:00:00 PDT

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.

Radical treatment and examination combined can halve mortality from prostate cancer

Wed, 10 Aug 2016 00:00:00 PDT

Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality...

Study finds marker of aggressive prostate cancer

Wed, 03 Aug 2016 05:00:00 PDT

May inform future tests to help doctors decide how best to treat prostate tumors.

Localized prostate cancer - a more accurate method to estimate risk at the point of diagnosis

Wed, 03 Aug 2016 05:00:00 PDT

Men diagnosed with prostate cancer can be provided with a more accurate estimate of their risk of death from the disease, and treatment planned accordingly, according to a Research Article...

UCLA researchers report high-dose radiation therapy as effective as surgery for aggressive prostate cancer

Tue, 02 Aug 2016 05:00:00 PDT

The research provides convincing evidence that radiation-based treatments and surgery are equally effective for aggressive prostate cancer.

First trial of robotic vs. non-robotic surgery for prostate cancer finds both achieve similar outcome at 3 months

Wed, 27 Jul 2016 05:00:00 PDT

Early results suggest similar quality of life outcomes at 3 months, but further follow-up is now needed from longer 2 year trial.

Markers that cause toxic radiotherapy side-effects in prostate cancer identified

Wed, 27 Jul 2016 00:00:00 PDT

A new study involving researchers from The University of Manchester looked at the genetic information of more than 1,500 prostate cancer patients and identified two variants linked to increased...

Prostate cancer: Unexpected results from international Phase III study

Tue, 12 Jul 2016 05:00:00 PDT

A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: the new therapeutic agent failed to achieve any...

Prostate cancer and DNA mutation: New connections revealed

Thu, 07 Jul 2016 00:00:00 PDT

A new relationship between mutations in specific DNA repair genes and metastatic prostate cancer is found. A new approach to treatment may be on the cards.

Robotic bottom may aid prostate cancer diagnosis

Mon, 04 Jul 2016 09:00:00 PDT

A robotic rectum may help doctors and nurses detect prostate cancer. The technology, which consists of prosthetic buttocks and rectum with in-built robotic technology, has been developed by...

NICE recommends FIRMAGON for men with advanced hormone-dependent prostate cancer and spinal metastases

Fri, 01 Jul 2016 05:00:00 PDT

Ferring Pharmaceuticals announced today that the National Institute for Health and Care Excellence (NICE) has recommended FIRMAGON® (degarelix) for a group of men with advanced...

New radiotherapy regime for prostate cancer could save NHS tens of millions per year

Tue, 21 Jun 2016 05:00:00 PDT

A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is as effective as the current standard treatment for both survival...

Laser ablation becomes increasingly viable treatment for prostate cancer

Mon, 13 Jun 2016 00:00:00 PDT

Prostate cancer patients may soon have a new option to treat their disease: laser heat.

Research reveals prostate cancer radiation treatment can be shortened by 50% with no loss of effectiveness

Wed, 08 Jun 2016 00:00:00 PDT

A shorter 4-week radiation regimen is non-inferior to the standard 8-week regimen when it comes to prostate cancer treatment, an Ontario-led study has found.

Study finds that higher BMI and waist circumference are associated with increased risk of aggressive prostate cancer

Fri, 03 Jun 2016 07:00:00 PDT

A study of almost 150,000 men from 8 European countries, presented at this year's European Obesity Summit (Gothenburg, 1-4 June) shows that higher body mass index (BMI) and waist circumference are...

Imaging biomarker distinguishes prostate cancer tumor grade

Thu, 02 Jun 2016 09:00:00 PDT

Enhanced imaging tool has potential to detect, grade, stage and guide treatment options.

FDA approves new diagnostic imaging agent to detect recurrent prostate cancer

Tue, 31 May 2016 09:00:00 PDT

The U.S. Food and Drug Administration has approved Axumin, a radioactive diagnostic agent for injection.

Genetic biomarker may predict nerve pain side effects associated with prostate cancer treatment

Mon, 16 May 2016 00:00:00 PDT

New study finds genetic alterations in the VAC14 gene are associated with an increased risk of docetaxel-induced peripheral neuropathy in prostate cancer patients.